But_home
But_blogshome
But_forum
Icon_rss_infobarSubscribe to receive updates
on new articles and posts from this blog.
 

STICH, EVEREST, RIVAL, and top interventional trials from ACC 2011

Btn-download-en

The STICH trial (reporting on CABG in HF patients), EVEREST (on MitraClip vs surgery), and a host of interventional trials were top news today at American College of Cardiology (ACC) 2011 Scientific Sessions. Learn the essentials.

See:

Docs say STICH "hypothesis one" supports CABG in HF patients despite missing primary end point

Latest from EVEREST II: MitraClip less effective but safer than surgery

Everolimus-eluting stent performs well in PLATINUM

PRECOMBAT: PCI noninferior to CABG for left main disease, but questions linger

Five-year data favor radial artery over saphenous vein grafts for CABG

Radial RIVALs femoral access for invasive ACS treatment, but doesn't beat it

New Resolute zotarolimus stent data flesh out efficacy, safety

Comments

Add your own comments



 


This blog on theheart.org is a sounding board for healthcare providers, clinicians, and researchers, and is not intended to supply answers or advice to patients. We reserve the right to remove posts containing inappropriate language, promotional content, personal agendas or hostile intent, and posts from patients asking for medical advice.

In the interest of promoting a balanced exchange, please disclose any relevant relationships or conflicts of interest when posting your comment.

The views and opinions expressed herein are those of the blogger and do not necessarily reflect those of theheart.org.